BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2031311)

  • 1. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M
    Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
    Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR
    Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen.
    Seifried E; Oethinger M; Tanswell P; Hoegee-de Nobel E; Nieuwenhuizen W
    Thromb Haemost; 1993 Apr; 69(4):321-7. PubMed ID: 8497843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effectiveness of streptokinase in acute myocardial infarct with respect to the pump function of the heart].
    Duraković Z; Smalcelj A; Radonić R; Ivanović D; Gasparović V; Gjurasin M; Bosnić D; Ljubojević B; Bogdan I; Grgić V
    Acta Med Iugosl; 1990; 44(3):185-96. PubMed ID: 2396487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolytic therapy of acute myocardial infarct in a district hospital. Analysis of a group of patients treated with streptokinase].
    Baraniková D; Renker B; Augustín E; Brunclík P
    Vnitr Lek; 1993 Mar; 39(3):260-5. PubMed ID: 8506678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
    Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
    Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Kharash LM; Goldkhammer EI
    Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct].
    Cassin M; Charmet PA; Rellini G; Molaro G; Bitto S; Brieda M; Zanuttini D
    G Ital Cardiol; 1987 Jul; 17(7):601-4. PubMed ID: 3678711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in hemocoagulation during thrombolytic therapy of acute myocardial infarct in relation to risks of thrombotic complications].
    Kessler P; Kubícková M
    Vnitr Lek; 1994 Jun; 40(6):354-8. PubMed ID: 8073644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
    Walker ID; Davidson JF; Rae AP; Hutton I; Lawrie TD
    Thromb Haemost; 1984 Apr; 51(2):204-6. PubMed ID: 6377564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
    Salvioni A; Marenzi GC; Agostoni P; Grazi S; Guazzi MD
    Eur Heart J; 1994 May; 15(5):654-9. PubMed ID: 8056006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical changes noted during intermittent administration of streptokinase.
    Verstraete M; Vermylen J; Schetz J
    Thromb Haemost; 1978 Feb; 39(1):61-8. PubMed ID: 148118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction.
    Lew AS; Berberian L; Cercek B; Lee S; Shah PK; Ganz W
    J Am Coll Cardiol; 1986 Jun; 7(6):1320-4. PubMed ID: 3711489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.